MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TN-02-0006825
Sanz Pharmaceuticals Private Limited
Sanz Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.2 Cr
▲ 107% YoY
Net profit · FY 2025
₹1.8 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹5.87 Lakh
EBITDA margin 1.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
38
Provident fund records
Directors on board
3
As per MCA filings
About Sanz Pharmaceuticals Private Limited
Data last updated:
Sanz Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2020PTC136511. Its GSTIN is 33ABDCS9990A1Z9 (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vishnupriya Ramasamy and Swaminathan Palaniappan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 19A 2nd Main Road Lakshmi Porur, Chennai, Tamil Nadu, India – 600116.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.2 Cr, a growth of 107% compared to the previous year. For the same year it recorded a net profit of ₹1.8 Lakh (net margin 0.3%) and EBITDA of ₹5.87 Lakh (EBITDA margin 1.1%).
The company has about 38 employees on its provident fund (EPFO) records.
Sanz Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0006825).
Company details
CIN U24100TN2020PTC136511
Registration Number 136511
Incorporation Date 19 July 2020
ROC Chennai
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0006825
Key People
Vishnupriya Ramasamy Director Swaminathan Palaniappan Director Swaminathan Annamalai Director Recognitions & Rankings of Sanz Pharmaceuticals
Contact details
Sanz Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered Address19A 2nd Main Road Lakshmi Porur, Chennai, Tamil Nadu, India – 600116
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sanz Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sanz Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sanz Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sanz Pharmaceuticals Private Limited, buy the company report.
Financials of Sanz Pharmaceuticals Private Limited
FY 2025 filings availableSanz Pharmaceuticals Private Limited reported revenue of ₹5.2 Cr (up 107% YoY) for FY 2025.
Revenue · FY 2025
₹5.2 Cr ▲ 107%
Net profit · FY 2025
₹1.8 Lakh margin 0.3%
EBITDA · FY 2025
₹5.87 Lakh margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 107%
EBITDA CAGR growth
3 years · compounded
▲ 175%
Revenue rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanz Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sanz Pharmaceuticals Private Limited
Sanz Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnupriya Ramasamy | Director | 19 Jul 2020 | 6 Years 3 Months | Current |
| Swaminathan Palaniappan | Director | 19 Jul 2020 | 6 Years 3 Months | Current |
| Swaminathan Annamalai | Director | 19 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Sanz Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Harihar Pharmaceuticals Private Limited | ₹5.32 Cr (FY 2025) | 7.0% | Bolangir, Odisha, India | |||
| Lucevida Pharmaceuticals Private Limited | ₹5.31 Cr (FY 2025) | 42.0% | Siliguri, West Bengal, India | |||
| Somu Chemicals and Pharmaceuticals Private Limited | ₹5.23 Cr (FY 2022) | 1.0% | Bangalore, Karnataka, India | |||
| Sanz Pharmaceuticals Private Limitedthis company | ₹5.2 Cr (FY 2025) | ₹1.8 Lakh | 0.3% | 107.0% | 38 | Chennai, Tamil Nadu, India |
| Austin Pharmaceuticals Limited | ₹5.19 Cr (FY 2024) | 49.0% | Chandigarh, India | |||
| Theta Pharmaceuticals Limited | ₹5.18 Cr (FY 2025) | -8.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sanz Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sanz Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sanz Pharmaceuticals Private Limited has a workforce of 38 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
38
Active EPFO establishments
1
Employee growth
18.8%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 38 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Sanz Pharmaceuticals Private Limited, buy the company report.
GST
Sanz Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33ABDCS9990A1Z9 | Tamil Nadu | Active | 29 Aug 2020 |
To see the full GST registrations and return filing status of Sanz Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sanz Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Swaminathan Annamalai was appointed as Director on 19 Jul 2020.
AGM
Sanz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sanz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Swaminathan Annamalai was appointed as Director.
Appointed
Swaminathan Palaniappan was appointed as Director.
Appointed
Vishnupriya Ramasamy was appointed as Director.
Incorporation
19 Jul 2020
Sanz Pharmaceuticals Private Limited was registered on 19 Jul 2020 with Roc Chennai & aged 6 years 3 months as per MCA records.
Frequently asked questions
Sanz Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 July 2020 (6+ years old) and is registered under CIN U24100TN2020PTC136511.
Sanz Pharmaceuticals has 3 current directors:
- Vishnupriya Ramasamy - Director
- Swaminathan Palaniappan - Director
- Swaminathan Annamalai - Director
The latest financial statements of Sanz Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Sanz Pharmaceuticals is 33ABDCS9990A1Z9, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Sanz Pharmaceuticals is U24100TN2020PTC136511. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanz Pharmaceuticals was incorporated on 19 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Sanz Pharmaceuticals by revenue are Harihar Pharmaceuticals Private Limited, Lucevida Pharmaceuticals Private Limited, Somu Chemicals and Pharmaceuticals Private Limited, Austin Pharmaceuticals Limited, Theta Pharmaceuticals Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Swaminathan Annamalai was appointed as Director on 19 Jul 2020. Swaminathan Palaniappan was appointed as Director on 19 Jul 2020. Vishnupriya Ramasamy was appointed as Director on 19 Jul 2020.
Yes, Sanz Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0006825).
The registered office of Sanz Pharmaceuticals is at 19A 2nd Main Road Lakshmi Porur, Chennai, Tamil Nadu, India – 600116.
Sanz Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages